Kewaunee Scientific Files 8-K on Other Events and Financial Exhibits
Ticker: KEQU · Form: 8-K · Filed: Feb 21, 2024 · CIK: 55529
| Field | Detail |
|---|---|
| Company | Kewaunee Scientific CORP /De/ (KEQU) |
| Form Type | 8-K |
| Filed Date | Feb 21, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, disclosure
TL;DR
**Kewaunee Scientific just dropped an 8-K for 'Other Events' and 'Financial Statements and Exhibits' on Feb 21, 2024, so keep an eye out for details!**
AI Summary
Kewaunee Scientific Corporation filed an 8-K on February 21, 2024, reporting an "Other Event" and "Financial Statements and Exhibits." The filing indicates a current report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934. The company, incorporated in Delaware with IRS Employer Identification No. 38-0715562, is headquartered at 2700 West Front Street, Statesville, NC 28677.
Why It Matters
This filing signals that Kewaunee Scientific has an event or information deemed significant enough to warrant immediate disclosure to investors, potentially impacting their understanding of the company's current state.
Risk Assessment
Risk Level: low — The filing itself is a standard disclosure and does not inherently indicate a specific risk without further details on the 'Other Event'.
Key Numbers
- 0000055529 — Central Index Key (CIK) (Unique identifier for the company with the SEC)
- 0-5286 — Commission File Number (SEC file number for the registrant)
- 38-0715562 — IRS Employer Identification No. (Tax identification number for the company)
- 20240221 — Conformed Period of Report (Date the report covers)
- 16 — Public Document Count (Number of public documents in the filing)
Key Players & Entities
- Kewaunee Scientific Corporation (company) — Registrant
- Delaware (company) — State of incorporation
- February 21, 2024 (date) — Date of report
- 2700 West Front Street, Statesville, NC 28677 (company) — Principal executive offices address
- 704-873-7 (dollar_amount) — Registrant's telephone number (partial)
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant as specified in its charter is Kewaunee Scientific Corporation.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is February 21, 2024.
Where are Kewaunee Scientific Corporation's principal executive offices located?
Kewaunee Scientific Corporation's principal executive offices are located at 2700 West Front Street, Statesville, NC 28677.
What items of information are included in this 8-K filing?
This 8-K filing includes 'Other Events' and 'Financial Statements and Exhibits' as per the ITEM INFORMATION section.
What is the state of incorporation for Kewaunee Scientific Corporation?
Kewaunee Scientific Corporation is incorporated in Delaware.
Filing Stats: 437 words · 2 min read · ~1 pages · Grade level 12.3 · Accepted 2024-02-21 16:28:01
Key Financial Figures
- $2.50 — ange on which registered Common Stock, $2.50 par value KEQU The Nasdaq Global Marke
Filing Documents
- kequ-20240221.htm (8-K) — 29KB
- prfy24q3earningsannounceme.htm (EX-99.1) — 9KB
- image_0a.jpg (GRAPHIC) — 7KB
- 0000055529-24-000003.txt ( ) — 174KB
- kequ-20240221.xsd (EX-101.SCH) — 2KB
- kequ-20240221_lab.xml (EX-101.LAB) — 23KB
- kequ-20240221_pre.xml (EX-101.PRE) — 12KB
- kequ-20240221_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events On February 21, 2024, Kewaunee Scientific Corporation announced that the Company plans to release its third quarter fiscal 2024 earnings on March 6, 2024. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Kewaunee Scientific Corporation dated February 21, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. KEWAUNEE SCIENTIFIC CORPORATION (Registrant) Date: February 21, 2024 By /s/ Donald T. Gardner III Donald T. Gardner III Vice President, Finance Chief Financial Officer